Taming Wild Fires Before They Spiral: Part 2 – User Experience
UF Innovate | Accelerate resident client Fire Neural Network (FNN) was spotlighted for its AI-powered wildfire detection system, which emphasizes user experience in addressing critical environmental challenges.
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement To Support ONP-002 Clinical Development
UF Innovate | Accelerate graduate Oragenics, Inc. has announced a manufacturing agreement with Sterling Pharma Solutions, a leading U.S.-based CDMO with multiple development and production facilities.
SandboxAQ and iOncologi Partner To Accelerate Brain Cancer Treatment With AI-Driven Drug Discovery for Glioblastoma
SandboxAQ and UF startup iOncologi have announced a strategic collaboration to co-develop, validate, and commercialize a novel high-fidelity mRNA vaccine targeting glioblastoma—the most common and aggressive malignant brain tumor in adults.
Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy To Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Solid Biosciences, which acquired UF startup AavantiBio, announced FDA and Health Canada approval to begin clinical trials of SGT-501, a gene therapy targeting CPVT, a severe heart rhythm disorder caused by RYR2 mutations.
TuHURA Biosciences Initiates Its Phase 3 Accelerated Approval Trial of IFx-2.0 as an Adjunctive Therapy to Keytruda® (Pembrolizumab) in First Line Treatment for Advanced or Metastatic Merkel Cell Carcinoma
TuHURA Biosciences, formed by CohBar and Morphogenesis, a UF startup, has announced the initiation of its Phase 3 accelerated approval trial of IFx-2.0, TuHURA's lead innate immune agonist, in patients with advanced or metastatic Merkel cell carcinoma (MCC).
Vertaeon, an Established Risk and Sustainability SaaS Platform Provider, Moves Deeper Into Artificial Intelligence With New Parent Entity AltaScient
UF Innovate | Accelerate client company Vertaeon is expanding its footprint in AI-powered risk analytics under its new parent entity, AltaScient.
Taming Wild Fires Before They Spiral – Part 1: Solutions
UF Innovate | Accelerate resident client Fire Neural Network (FNN) was spotlighted for its AI-driven wildfire detection platform, which aims to prevent devastating blazes by catching them early with low-cost sensors and advanced analytics.
Florida Venture Forum and Space Florida Announce Winners of $150,000 in 2025 Early Stage Venture Conference Investment
Florida Venture Forum, Florida’s largest statewide support organization for investors and entrepreneurs, announced the recipients of $150,000 in award dollars and investment from Space Florida during its 17th annual Early Stage Venture Conference in Orlando.
XPRIZE UF
UF Innovate | The Hub resident client FNN, in collaboration with UF researchers, advances to the semi-finals of the XPRIZE Wildfire competition with its AI-driven technology aimed at early detection and suppression of wildfires.
Oragenics, Inc. Announces Approval To Initiate Phase II Concussion Drug Trial in Australia
UF Innovate | Accelerate graduate Oragenics announced that it has received approval from the Human Research Ethics Committee (HREC) in Australia to initiate a Phase II clinical trial evaluating ONP-002 for the treatment of mild traumatic brain injury (mTBI).
